MK2 is a therapeutic target for high-risk multiple myeloma
oleh: Chunyan Gu, Haibo Cheng, Hongbao Yang, Yong Bian, Yaohui Wang, Yifen Zhang, Michael Pisano, Gang Hu, Ye Yang
| Format: | Article |
|---|---|
| Diterbitkan: | Ferrata Storti Foundation 2018-03-01 |
Deskripsi
No description available for this item.